13 patents currently held
12 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8 more records may belong here and await a decision; they are not counted.
The next term ends in Dec 2027. from the record
Of the 12 now held by other companies, 12 name Akoya Biosciences Inc. as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
10
Ending by 2030
Dec 2027
Next term end
8
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Feb 2030 · High confidence
Also notable
Ends Apr 2029 · High confidence
Also notable
Ends Sep 2028 · High confidence
Also notable
Ends Aug 2030 · High confidence
Also notable
Ends Mar 2033 · High confidence
Also notable
Ends Jul 2034 · High confidence
Also notable
Ends Dec 2027 · High confidence
Also notable
Ends Sep 2030 · High confidence
Multi-Spectral Imaging Including at Least One Common Stain
US 8,280,134
Cited by 80 later US patents, top 10% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Systems and Methods for In-Vivo Optical Imaging and Measurement
US 7,873,407
The most cited patent in this portfolio, cited by 86 later US patents, top 10% of utility patents granted in 2011 in our data. Protection runs to 2029.
Systems and Methods for In-Vivo Optical Imaging and Measurement
US 8,103,331
Cited by 45 later US patents, top 25% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Classification of Samples
US 8,103,081
Cited by 61 later US patents, top 10% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Visualization of Stained Samples
US 9,002,077
Cited by 40 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2033.
Sample Imaging and Classification
US 9,262,697
Cited by 23 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Surface Measurement of In-Vivo Subjects Using Spot Projector
US 7,990,545
Cited by 39 later US patents, top 25% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
Sample Imaging and Classification
US 8,126,205
Cited by 24 later US patents, top 25% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Formerly held, still cited
Notable
Ends Mar 2028 · High confidence
The most cited patent in this portfolio, cited by 157 later US patents, top 5% of utility patents granted in 2009 in our data. Protection runs to 2028.
now held by Akoya Biosciences, Inc.
Also notable
Ends Oct 2030 · High confidence
Cited by 76 later US patents, top 10% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
now held by Akoya Biosciences, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 7, 2027The maintenance fee for Systems and Methods for In-Vivo Optical Imaging and Measurement (US 11,806,111) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
- 1 fee due Aug 16, 2027The maintenance fee for Sample Imaging and Classification (US 9,262,697) comes due Aug 16, 2027. Unpaid by Feb 16, 2028, it lapses early.
Recent changes
- 2 terms have ended since Aug 23, 2026
- Nov 10 US 8,634,607 Spectral Imaging of Biological Samples · term ended
- Aug 25 US 7,477,931 Systems and Methods for In-Vivo Optical Imaging and Measurement · term ended
What they patent
The 3 largest of its 8 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Birefringent Filter Using Reflective Polarizers and Dichroic Elements | 4 in force | to Dec 2029 |
| Multi-Spectral Imaging Including at Least One Common Stain | 2 in force | to Nov 2032 |
| Systems and Methods for In-Vivo Optical Imaging and Measurement | 2 in force | to Sep 2028 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,782,470 | Surface Measurement Apparatus and Method Using Depth of Field In force · High confidence | In force | High confidence | |
| US 7,990,545 | Surface Measurement of In-Vivo Subjects Using Spot Projector In force · High confidence | In force | High confidence | |
| US 11,806,111 | Systems and Methods for In-Vivo Optical Imaging and Measurement In force · High confidence | In force | High confidence | |
| US 7,982,955 | Birefringent Filter Using Reflective Polarizers and Dichroic Elements In force · High confidence | In force | High confidence | |
| US 8,103,331 | Systems and Methods for In-Vivo Optical Imaging and Measurement In force · High confidence | In force | High confidence | |
| US 7,873,407 | Systems and Methods for In-Vivo Optical Imaging and Measurement In force · High confidence | In force | High confidence | |
| US 7,995,205 | Visualizing Birefringent Structures in Samples In force · High confidence | In force | High confidence | |
| US 8,280,134 | Multi-Spectral Imaging Including at Least One Common Stain In force · High confidence | In force | High confidence | |
| US 8,103,081 | Classification of Samples In force · High confidence | In force | High confidence | |
| US 8,126,205 | Sample Imaging and Classification In force · High confidence | In force | High confidence |
Also on record, not counted in the 13: 12 patents in force now held by others · 28 patents ended · 9 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.